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Depression is now considered to be the world’s
fourth greatest public health problem.1 A great
deal of evidence on the outcome and course of
this disorder shows that depression is a chronic
and recurrent disorder in contrast to Krepalin’s
earlier concept.2–5 Chronic depression develops
in more than 20% of patients after an index
episode. Partial recovery will occur in 15–20% of
patients and 15–35% of patients who recover
will relapse within 1–2 years.2,6–9 The estimated
probability of remaining ill for at least 5 years
was 11.5%.3 rAmong those who were not well fo
t the first 5 years, 38% recovered within the nex
5 years.1 Only a quarter of patients recovered from
an index episode and remained well for more
than 10 years thereafter. For more than one in 10
patients, depression proved to be persistent; the
yproportion of patients affected remained relativel
stable over time.10
cReview of a limited number of naturalisti
outcome studies of affective disorders in which
y depression was followed up for approximatel
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Background/Purpose: A wide range of recovery rates has been reported during the 1st year of follow-up in
patients with depression, and there is a lack of consensus regarding which clinical and psychosocial vari-
ables are associated with prognosis. This study investigated the outcome of inpatients with a major depres-
sive episode at 10–22 months (mean ± SD = 14.0 ± 3.4 months) of follow-up and the associated psychosocial
and clinical variables.
Methods: The demographic and clinical characteristics of 67 inpatients with a DSM-IV major depressive
episode were assessed at admission, discharge and 1 year after the initial assessment. A logistic regression
model was used to examine the predictive factors of depressive status at follow-up.
Results: At the 1-year follow-up, 12 patients could not be located, one refused further interview and one
had committed suicide 1 month after discharge. Eighty percent of patients had follow-up examinations.
Out of 67 patients, 31 (47%) underwent a DSM-IV diagnosis (29 with major depression and two with
minor depression) and 22 (33%) recovered. Low socioeconomic status (p = 0.05), long duration of illness
before admission (p = 0.03) and number of previous hospitalizations (p = r0.04) were predictive factors fo
a depressive morbidity at 10–22 months.
Conclusion: At follow-up, almost half of the discharged depressive patients were still depressed.
gScreening for predictive factors of chronic depressive morbidity facilitates better outcome by considerin
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ORIGINAL ARTICLE
1 year showed a wide range of recovery rates from
depression (35–75%).10 There is also no consensus
regarding which clinical and psychosocial variables
are associated with prognosis. Several method-
ologic considerations hamper comparison of the
results from the few available naturalistic studies.
Follow-up studies of patients with depressive dis-
orders varied widely in definitions of recovery and
follow-up period (determined from the starting
point since disease onset, enrollment into a study
or discontinuation of inpatient treatment), in
methods of study design (prospective and periodic
assessments with short intervals or assessment at
an end point) and outcome assessments (depres-
sion defined by an interview method or by ques-
tionnaires), as well as in composition of subjects
from the community, outpatients or inpatients.
This study aims to investigate the outcome sta-
tus of depressive inpatients at 10–22 months’ fol-
low-up and the effects of psychosocial and clinical
variables (including inpatient treatment) on in-
termediate-term clinical outcome after discharge.
Methods
Subjects
Sixty-seven patients with a current episode of
DSM-IV major depressive disorder (MDD) with-
out psychotic features who were consecutively
admitted to a psychosomatic ward of a university
hospital from October 2000 to June 2001 were
included. None of these patients had a previous
episode of hypomania or mania. Three patients
had repeated hospitalization during the study
period and therefore received study assessment
only once. These subjects were originally recruited
as a pretest group of outcome in a clinical path-
way for depressive inpatients. 
Measurements
Data recorded for each patient included age at
onset of depression, number of previous hospi-
talizations, duration of illness before index ad-
mission, family history of psychiatric illness, the
presence of coexisting disorders, concomitant
suicide attempt and length of hospital stay. Socio-
economic status (SES) was stratified into quintile
categories, classes I–V, ordered from highest to
lowest and based on education and occupation
of key person in their family.11
The Hamilton Rating Scale for Depression
y(HAM-D) and the Beck Depression Inventor
(BDI) were used to assess the severity of depres-
sion as well as the treatment response of depres-
sion.12,13  Response to treatment was defined as
a HAM-D score at discharge that had decreased
by more than 50% from baseline, and remission
of depression as a HAM-D score ≤ 7.14 tA recen
fstudy comparing the reliability and validity o
face-to-face and phone interviews for HAM-D
found high levels of agreement (Pearson’s corre-
lation coefficient r = 0.748).15
The Global Assessment of Functioning (GAF)
tscale was used to provide a clinician’s assessmen
of a patient’s overall level of functioning on a hy-
pothetical continuum of mental health illness.
The Maudsley Personality Inventory (MPI)
yby Eysenck measures two aspects of personalit
characteristics: neuroticism and extroversion.16
yIts psychometric properties and time stabilit
yhave been demonstrated, and it has been widel
used in both community and medical settings in
Taiwan since the 1970s.17,18
yThe Family APGAR index, developed b
gSmilkstein in 1978, is a family function-screenin
fquestionnaire, which measures the perception o
five components of family function: adaptation,
partnership, growth, affection and resolve.19,20 A
yhigher score indicates a higher level of famil
support.
The Mini International Neuropsychiatric In-
cterview (MINI) is a short structured diagnosti
interview, developed jointly by psychiatrists and
rclinicians in the United States and Europe, fo
DSM-IV and ICD-10 psychiatric disorder.21 In
t1999, after obtaining a permission agreemen
from the original authors, MINI was translated
into Chinese by a two-step procedure (transla-
tion and back-translation) in Taiwan. A research
and development team was organized, and sen-
ior psychiatrists working in medical centers and
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psychiatric institutes were invited to discuss and
examine the content validity of the Taiwanese
version of the MINI on several occasions. A psy-
chiatrist experienced with the use of this instru-
ment was also invited to attend the training
workshop conducted by the Taiwanese Society of
Psychiatry in Taipei, and MINI training was held
annually and integrated into the resident training
programs in our department.
Procedure
Acute phase: During the 1st week of hospitaliza-
tion, attending psychiatrists rated the severity of
depression and functioning level of the hospital-
ized patients with the HAM-D-17 and GAF scales.
Patients were also asked to complete the BDI,
MPI and Family APGAR. Three days before dis-
charge, these assessments were repeated except
for the MPI and Family APGAR.
Follow-up: Follow-up was conducted begin-
ning at approximately 1 year after patients were
discharged from hospital. The mean duration of
follow-up (from the time of discharge to the time
at follow-up) was 14.0 ± 3.4 (10–22) months.
One of the authors collected data on sociodemo-
graphic and clinical characteristics during the
index admission using the chart review method. 
Sixty-seven patients were contacted by tele-
phone or by mail according to their previously
known addresses. The purpose of the initial con-
tact included addressing the aim of this study
and invitation for a follow-up interview after ob-
taining written consent. The follow-up interview
was conducted over the telephone if patients
were not available for face-to-face interview at
the hospital. Follow-up assessments comprised
two parts: patients’ interviews and self-report
questionnaire (BDI). A senior psychiatrist con-
ducted a structured diagnostic interview (MINI)
to establish each patient’s diagnostic status and
HAM-D and GAF evaluation at follow-up.
This study was naturalistic by design. Infor-
mation was collected on treatments received in
hospital and after discharge, but no attempt was
made to control the amount or type of therapy
given to patients.
Statistical analyses
cDescriptive statistics were used to analyze basi
demographic data. For the purpose of comparison,
ythe denominator of rates of follow-up in this stud
as well as other comparative studies included all
originally recruited patients. Paired t test was used
to compare the psychometric scores (HAM-D, BDI
and GAF) between admission and discharge. In the
analysis, the depression outcome variable was di-
chotomized into case group or recovery group.
Recovery from a depressive episode was defined
tas absence of DSM-IV depressive disorders for a
least 8 weeks according to status at 1-year follow-
up after discharge from hospital. Differences in
variables between the two groups were compared
with t or χ2 tests for continuous or categorical
cvariables, respectively. All the sociodemographi
cand clinical variables (included psychometri
scores) were examined for relationship with out-
tcome of depression at follow-up. If a significan
bivariate relationship was found, the factor was
included in a multivariate logistic regression model
rto determine if it was an independent predicto
of depressive status at follow-up. All data were
analyzed using SPSS version 10.0 (SPSS Inc.,
Chicago, IL, USA) for Windows.
Results
Basic and clinical characteristics
Most of the patients were women (n = 48, 71.9%),
and the mean age of the patients at admission was
49.2 ± f15.4 years. Thirty-one percent and 42% o
the patients were in upper or middle SES cate-
gories, respectively. The mean duration of the
index episode of MDD prior to study entrance
was 6.0 ± 8.7 months, with nearly 60% of them
less than 3 months. The index episode was the
patient’s first episode for 40% of all patients, and
24% had at least two prior episodes.
Treatment response and clinical status 
at discharge
fAll patients received an equivalent dosage o
178.7 ± 64.7 mg imipramine or 35.7 ± g12.9 m
fIntermediate-term outcome o  inpatients with major depression
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fluoxetine during hospitalization.22 After an 
average of 25 days of hospitalization, 79%
(n = 53) of all patients responded to treatment
(defined by HAM-D score < 50% of original
score), and 60% (n = 40) achieved remission
(HAM-D ≤ 7) at discharge. Psychometric scores
including HAM-D (22.4 vs. 7.7, t = 17.0, p <
0.001), BDI (31.9 vs. 20.9, t = 6.6, p < 0.001) and
GAF (45.5 vs. 69.8, t = −14.6, p < 0.001) were sig-
nificantly improved at discharge compared with
at admission.
Attrition
At follow-up, 12 patients could not be located,
one refused interview and one had committed
suicide by jumping from a building 1 month after
discharge. Among the patients successfully con-
tacted, 53 completed the study yielding a par-
ticipation rate of 80.3% (excluding the 1 patient
who died). Forty-seven patients (88.7%) were in-
terviewed face-to-face, and the remaining (11.3%)
were interviewed by telephone. No significant
differences in demographic or clinical variables
were found between patients who dropped out
and those who completed the study. Most of the
attrition cases (85.7%) were in a state of remis-
sion at discharge. 
Outcome status at follow-up
Good drug compliance during the follow-up
period was reported by about 80% of pa-
tients. The equivalent dose was 131.9 ± 78.1 mg
imipramine or 26.4 ± 15.6 mg fluoxetine. Forty-
seven percent of 67 patients (n = 31) met the 
criteria for DSM-IV depressive disorders at 
follow-up and were labeled as the case group.
Among them, 93.5% (n = 29) met the criteria for
MDD and 6.5% (n = 2) for minor depressive dis-
order. Thirty-three percent (n = 22) of patients
had no or minimal symptoms of depression for
at least 8 weeks at follow-up and were designated
as the recovery group. Among them, only one-
quarter of 67 patients (n = 17, 25.4%) had recov-
ered from the index episode and remained well
during the follow-up period. The HAM-D scores
for the two groups at follow-up were 18.4 ± 6.9
and 4.4 ± 3.8, respectively. The BDI scores were
29.5 ± 8.8 and 7.6 ± 9.7, respectively. The outcome
gfor the 20% of this sample that was lost durin
follow-up or declined follow-up examinations was
unknown.
Predictive factors for depression outcome at
10–22 months of follow-up
Clinical and sociodemographic factors signifi-
cantly related to depressive illness at follow-up
included SES (p = x0.01), suicide attempt at inde
episode (p = 0.05), number of previous hospital-
izations (p = 0.03) and longer duration of illness
before index admission (p = 0.04) (Table 1). There
were no significant differences in outcome status
at around 1 year based on patients’ sex, age, mar-
ital status, age at onset of depression, family his-
tory of psychiatric illness, presence of comorbid
physical illness, treatment modality (combina-
tion of antipsychotics or electroconvulsive ther-
apy), length of hospital stay, severity of symptoms
(BDI, HAM-D and GAF scores) at index admis-
sion, neuroticism scores of MPI, Family APGAR,
tremission status at discharge or compliance a
toutpatient follow-up. The best model to predic
rdepressive illness at follow-up showed that lowe
SES, longer duration of illness before entry, more
frequent previous hospitalizations and suicide
kattempt at index episode were significant ris
factors (Table 2). The final adjusted model cor-
rectly identified 81.1% of the cases.
Discussion
rComparison of our results with those of Keitne
et al23 showed that our patients had a similar rate
of depression at follow-up (47% vs r. 46%), a lowe
rate of recovery (33% vs. 44%) and a higher attri-
tion rate (20% vs. 10%). Previous studies which
yused different methods to examine the recover
rate found a higher percentage of patients recov-
ered including 62% in Sargeant et al’s study,24
54.2% in Ezquiaga et al’s study25 rand 74% in Kelle
and Shapiro’s 1-year follow-up results.8 tSargean
ret al adopted the presence or absence of majo
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depression after 1 year as the outcome variable
in a community population. Ezquiaga et al fol-
lowed up 72 outpatients suffering from a uni-
polar major depression, using a prospective,
periodic assessment of HAM-D and other psy-
chosocial variables. The lower rate of persistent
depression perhaps reflected the presence of less
tsevere illnesses in the community and outpatien
ygroup. Keller et al’s study defined rates of recover
and subsequent relapse in terms of the percent-
age recovered and/or relapsed at any time up to 1
year rather than in terms of how well patients
fwere at the time of follow-up. The inclusion o
some outpatients is another possible explanation
fIntermediate-term outcome o  inpatients with major depression
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Table 1. Comparison of characteristics of patients with depression and recovery at 1-year follow-up
Depression at follow-up Recovered at follow-up
(n = 31) (n = 22)
Sex, female (%) 71.0 68.2
Marital status (%) 25.8 36.4
SES, I & II (%)* 19.4 59.1
Mean age (yr) 50.1 51.6 
Mean age at onset (yr) 45.3 46.3
Family history of psychiatric illness (%) 12.9 18.2
Comorbidity with physical illness (%) 35.5 50.0
Previous hospitalization (n)† 1.0 0.2
Previous hospitalization ≥ 2 (%)† 19.4 0
Suicide attempt at index episode (%)† 38.7 13.6
Mean duration of index episode (mo)† 8.9 3.9
Length of stay (d) 26.7 26.0
Treatment
With antipsychotic (%) 22.6 18.2
With ECT (%) 9.7 0
Remission status at discharge (%) 58.5 45.5
Psychometric scores at admission (mean ± SD)
BDI 32.5 ± 11.1 30.0 ± 12.6
HAM-D 21.9 ± 7.7 23.5 ± 7.4
GAF 44.4 ± 10.1 44.8 ± 9.5
Neuroticism of MPI 15.6 ± 5.4 14.6 ± 3.9
Family APGAR 5.8 ± 4.3 5.9 ± 4.2
*p < 0.01; †p < 0.05. SES = socioeconomic status; ECT = electroconvulsive therapy; BDI = Beck Depression Inventory; HAM-D = Hamilton
Rating Scale for Depression; GAF = Global Assessment of Functioning; MPI = Maudsley Personality Inventory.
Table 2. Logistic regression analysis of risk factors with depression outcome at follow-up
Risk factors β SE p OR
95% CI for OR
Lower Upper
SES* 0.96 0.50 0.05 2.61 0.98 6.89
Duration of illness before entry (d)† 0.16 0.71 0.03 1.17 1.02 1.35
Number of previous hospitalizations 1.42 0.68 0.04 4.14 1.10 15.55
Suicide attempt at index admission 1.35 0.83 0.10 3.87 0.76 19.75
Note: A multiplier greater than 1 indicates an increased likelihood of depression persistence at follow-up.
*Lower SES increased the odds of being depressed at follow-up (1 = upper SES, 2 = middle SES, 3 = lower SES); †longer duration of ill-
ness significantly increased the odds of being depressed at follow-up. CI = confidence interval; OR = odds ratio; SES = socioeconomic
status.
for why Keller et al’s patients had better out-
come. In agreement with Keller et al’s results
(30%), our study found that only 25.4% of pa-
tients had recovered from the index episode and
remained symptom free for the remainder of the
1-year follow-up period.
In this study, the only demographic factor pre-
dictive of depression at 1 year was sociodemo-
graphic status. The effects of age, sex and marital
status on the course and outcome of depression
were not confirmed in many follow-up studies,
as well as in this study. In previous studies, SES was
not consistently implied to have a relationship
with persistence of depression. Low family income
or low level of education was found to be a pre-
dictor of chronicity in two previous studies.7,26
Another meta-analysis regarding the relationship
of SES and depression indicated that individuals
with low SES had higher odds of being depressed
(odds ratio [OR], 1.81).27 Once depressed, indi-
viduals with lower SES were much more likely to
have persistent depression (OR , 2.06).
Only two clinical variables, longer duration
of illness and more frequent hospitalizations,
were associated with persistence of depression at
follow-up in this study. The significance of sui-
cide attempts disappeared after adding number
of previous hospitalizations as a variable in the
logistic regression model. Several previous stud-
ies of community- and patient-based samples
have demonstrated the relationship between du-
ration of illness and depressive outcome.7,8,24,28–30
The number of previous hospitalizations was also
related to depressive outcome in two studies.8,23
Patients who had suffered from index depressive
episode for a longer time before admission or had
more previous hospitalizations were at a higher
risk of a chronic disease course. This result high-
lights the need for depressed patients to receive
early inpatient treatment. However, decisions for
hospitalization should be adequately considered
based on the benefit of early admission to prevent
chronicity of depression and the cost of repeated
hospitalizations that reinforce chronicity.
Severity at presentation,24 length of stay,23 age
at onset,23 social support26,31 and remission from
depression with residual symptoms32 have been
described as predictors of persistent depression
in previous follow-up studies. A high level of neu-
roticism was reported to be associated with a
slower time to recovery.33,34 None of the above
rfactors was confirmed as an outcome predicto
in this study. An inadequate treatment regimen
was assumed to be responsible for the unfavorable
outcome of depressive episodes in patients with
personality pathology.26,35 Our patients received
an adequate dosage and duration of antidepres-
gsants as well as psychosocial treatment durin
hospitalization and follow-up. Remission status
was defined according to assessments performed
at discharge (when clinical conditions reached
tsteady progress or chronic stable) instead of a
regular time intervals after starting treatment.
The above two reasons might explain why no sig-
nificant relationship was found between some
factors (high level of neuroticism, severity of pre-
sentation and remission status at discharge) and
persistent depression in this study. 
This study had several limitations. First, the
study design was naturalistic, i.e., treatment was
not assigned by design but left to the discretion
tof the patients. Therefore, assessment of the effec
of treatment in this study is problematic. Second,
yresearchers assessed patients’ clinical status onl
at admission, discharge and 10–22 months later.
Data collected from the patients regarding the
clinical course might be biased by patients’ re-
call. Recovery followed by relapse or recurrence
at the time of follow-up would lead to underesti-
gmation of the recovery rate. Third, the resultin
bias toward underestimating outcome was con-
founded by lack of follow-up in some subjects.
f In conclusion, at 1-year follow-up, nearly hal
of the discharged depressive patients were still
depressed; only one-quarter of them had sus-
tained recovery throughout the follow-up pe-
riod. Lower SES, longer duration of illness before
admission and greater number of previous hos-
pitalizations were risk factors associated with
lack of recovery at 1 year after a depressive
episode in order of significance. For patients with
a discrete episode of depression, early admission
M.C. Tseng, et al
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to shorten the duration of the current episode
might provide an alternative treatment modality
to lessen the risk of continued depression at follow-
up. However, for patients with chronic depressive
symptoms and poor response to previous treat-
ment, the benefit of inpatient therapy should be
balanced against the cost of repeated hospitali-
zations that might also enhance the chronicity of 
depression itself. Screening for risk factors of con-
tinued depression facilitates optimal treatment
based on the heterogeneity of psychopathology.
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